Albuminuria means there's a small amount of a protein called albumin in your urine. This can be a sign that your kidneys aren't working properly. Doctors often check urine for albumin to look for kidney problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Cozaar (Losartan) for Albumin in Urine?
Albumin in urine, also called albuminuria, means that albumin, a protein that normally stays in the blood, is passing into the urine. Healthy kidneys filter waste out of the blood while holding on to useful proteins like albumin. When the kidneys' tiny filters are damaged or under strain, albumin leaks through. Albuminuria is not a disease in itself. It is a sign that something is affecting the kidneys, most often diabetes or high blood pressure, and it is one of the two main ways kidney disease is detected. It matters for two reasons. It can reveal kidney damage early, even when blood tests of kidney function still look normal. And the more albumin there is, the higher the risk of kidney failure, heart attack, stroke and heart failure. Most people with albuminuria feel completely well, so it is usually found through a routine urine test.
Lasting albuminuria usually reflects damage to the kidneys' filters. Diabetes is the most common cause, particularly when blood sugar has been above target for years, followed by high blood pressure. Heart disease and heart failure can also contribute, as can diseases that inflame or scar the filters directly, such as IgA nephropathy, lupus nephritis and focal segmental glomerulosclerosis (FSGS). Often more than one cause is at work. Albumin can also rise for a short time without lasting damage. Hard exercise in the previous day, fever, an infection (including a urinary tract infection), dehydration, a flare of heart failure, very high blood sugar or blood pressure, and menstruation can all push a single result up. The main reasons to be tested are diabetes, high blood pressure, heart disease, obesity, smoking, age over 50 and a family history of kidney disease, diabetes or high blood pressure. These raise the likelihood of kidney disease; they do not mean someone will develop it.
The standard test is the urine albumin-to-creatinine ratio (UACR), sometimes still called a microalbumin test. It uses a single urine sample, usually given at a clinic or lab. Because urine is more or less concentrated depending on how much someone has drunk, the lab compares albumin with creatinine, a waste product the kidneys release at a fairly steady rate. The result is given in milligrams of albumin per gram of creatinine (mg/g). Testing is recommended at least once a year for everyone with type 2 diabetes and for people who have had type 1 diabetes for five years or more. In adults, a UACR under 30 mg/g is considered normal. A result from 30 to 299 mg/g is moderately increased, and 300 mg/g or higher is severely increased. These ranges are not a sharp line between safe and unsafe: risk rises steadily with the number, so a result of 250 carries more risk than a result of 40. The older terms microalbuminuria and macroalbuminuria roughly match the two raised ranges. Because albumin levels vary a lot from day to day, one high result is not a diagnosis. Albuminuria is confirmed when at least two of three samples collected over three to six months are raised, ideally taken when the person is well and has not just exercised hard. An office dipstick test can detect albumin but is less precise, so a positive dipstick is followed by a laboratory UACR. A blood test for estimated glomerular filtration rate (eGFR), which shows how well the kidneys filter, is done alongside it. Confirmed albuminuria can indicate chronic kidney disease even when eGFR is above 60, the usual normal threshold. If the cause is unclear, the level is very high, or blood also appears in the urine, further tests such as a kidney ultrasound or, sometimes, a kidney biopsy may be considered.
Treatment aims to protect the kidneys and heart by treating the cause and reducing how much albumin leaks. Lower albumin levels are linked to better kidney and heart outcomes, and bringing the number down helps even when it does not fall below 30. If a raised result turns out to be temporary, the usual next step is simply rechecking it. The foundation is control of the underlying condition. For diabetes, that means keeping blood sugar near the agreed target. For blood pressure, many people with kidney disease aim for a reading below 130/80, meaning a top number under 130 and a bottom number under 80, and some guidelines aim lower when that can be done safely. Not smoking, limiting sodium, staying physically active, limiting alcohol and losing excess weight where relevant all support this. Several medicines protect the kidneys beyond lowering blood pressure or blood sugar. Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, or angiotensin receptor blockers (ARBs), such as losartan, are usually the first choice for persistent albuminuria, especially at higher levels or with diabetes. They lower the pressure inside the kidney's filters. They are used one at a time rather than together, at the highest dose a person tolerates. Potassium and kidney function are checked by blood test within a few weeks of starting or raising the dose. A small early rise in creatinine is expected and is not usually a reason to stop. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin (Farxiga) and empagliflozin (Jardiance), were developed for diabetes but also slow kidney disease, including in many people without diabetes. Guidelines recommend them for chronic kidney disease with substantial albuminuria (200 mg/g or more) and for people with type 2 diabetes and kidney disease. Genital yeast infections are the most common side effect, and these medicines are usually paused during prolonged fasting, surgery or serious illness. For people with diabetes whose albuminuria persists despite these treatments, finerenone (Kerendia), a newer kidney-protective tablet called a nonsteroidal mineralocorticoid receptor antagonist, can be added; it also needs potassium checks. Semaglutide (Ozempic), a diabetes medicine of the glucagon-like peptide 1 (GLP-1) receptor agonist type, is approved to slow kidney decline in people with type 2 diabetes and kidney disease. Pregnancy changes these choices. ACE inhibitors, ARBs, finerenone and SGLT2 inhibitors can harm a developing baby, so anyone who could become pregnant should discuss contraception and, if planning a pregnancy, switch to safer medicines before conceiving. When a specific disease of the kidney filters is the cause, a kidney specialist may add treatment aimed at that disease.
Albuminuria is usually a long-term finding that is monitored over time, and its course varies. With treatment, many people see their UACR fall, and a level that stays stable or comes down is a sign the plan is working. Others see slow increases over years. Kidney damage that has already happened generally cannot be undone, but slowing it is a realistic goal, and finding albuminuria early leaves more time to act. Daily life is usually unaffected, since most people have no symptoms. The practical work is routine: taking medicines consistently, repeating urine and blood tests between one and four times a year depending on kidney function and albumin level, checking blood pressure at home if advised, and paying attention to blood sugar, diet and activity. Because albuminuria also signals higher heart risk, care often includes a statin to lower cholesterol and other heart-protective steps. Medicines are adjusted over time based on potassium, eGFR and the albumin trend.
Ask about a urine albumin test if you have diabetes, high blood pressure, heart disease or a family history of kidney failure and have not been tested in the past year, or if an earlier result was raised and never rechecked. Ask about referral to a kidney specialist (nephrologist) if albumin is rising quickly, eGFR is falling quickly or is below 30, albuminuria is very high or comes with blood in the urine, or the cause is unclear. Contact your care team soon if you notice new swelling of the feet, ankles, belly or face, puffiness around the eyes, or urine that stays foamy, since these can mean heavier protein loss or worsening kidney disease. Contact your prescriber promptly if you become pregnant, or plan to, while taking a kidney-protective medicine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Albumin in Urine is like, what's helped you, or ask the community a question.